RUBY Insider Trading - Rubius Therapeutics, Inc.

Innsideraksjer

12 156 127 shares

Insider Sentiment Score

Insider Sentiment Score finner selskapene som blir kjøpt av bedriftsinsidere.

Det er resultatet av en sofistikert, flerfaktor kvantitativ modell som identifiserer selskaper som har de høyeste nivåene av insiderakkumulasjon. Scoringsmodellen bruker en kombinasjon av netto antall insidere som kjøper de siste 90 dagene, det totale antallet kjøpte aksjer som en prosentandel av flyten, og det totale antallet aksjer eid av insidere. Tallet varierer fra 0 til 100, hvor høyere tall indikerer en høyere grad av akkumulasjon sammenlignet med jevnaldrende, og 50 er gjennomsnittet.

Oppdateringsfrekvens: Daglig

Se Insidernes Topp Picks, som gir en liste over selskaper med høyest akkumulasjon blant insidere.

Se høyest rangerte aksjer

Officer Sentiment Score

Officer Sentiment Score finner selskaper som kjøpes av bedriftsoffiserer.

Per definisjon er Corporate Officers Corporate Insiders, men i motsetning til noen av de andre innsiderne (10 % aksjonærer og styremedlemmer), jobber offiserer for selskapet på daglig basis, og de bruker sine egne penger når de handler . (10 % aksjonærer og styremedlemmer er ofte fondsforvaltere som forvalter andres penger.) Som sådan er innsidehandler utført av offiserer mye mer betydningsfulle og bør behandles på riktig måte.

Som Insider Sentiment Score er Officer Sentiment Score resultatet av en sofistikert, flerfaktor kvantitativ modell som identifiserer selskaper med de høyeste nivåene av akkumulasjon blant ledelsen.

Oppdateringsfrekvens: Daglig

Se Insidernes Topp Picks, som gir en liste over selskaper med høyest insider-sentiment.

Se høyest rangerte aksjer

Nøkkelindikatorer for insidere

Dette kortet viser hvordan selskapet rangerer langs ulike indikatorer for insidere. Percentile-rangeringen viser hvordan dette selskapet sammenligner seg med andre selskaper på USAs markeder. Høyere rangeringer indikerer bedre situasjoner.

For eksempel, er det generelt akseptert at insiderkjøp er en positiv indikator, så derfor ville selskaper som insiderkjøper mer, rangere høyere enn selskaper med mindre insiderkjøp (eller til og med insidersalg).

Netto antall insidere som kjøper (Rangering)

N/A

Nettotall av innsidekjøp som kjøper er det totale antallet insidere som har kjøpt minus det totale antallet insidere som har solgt de siste 90 dagene. Den prosentvise rangeringen vises her (rangerer fra 0 til 100%).

Prosent av aksjeflyt kjøpt av insidere (rang)

N/A

Prosenten av aksjeflyt kjøpt av innsidere er det totale antallet aksjer som er blitt kjøpt av innsidere minus det totale antallet aksjer solgt av innsidere de siste 90 dagene, delt på totalt antall utestående aksjer og multiplisert med 100.

Diagram over innsidehandel

Rubius Therapeutics, Inc. insiderhandel vises i følgende diagram. Innsidere er ledere, direktører eller viktige investorer i et selskap. Generelt sett er det ulovlig for insidere å handle med aksjer i sine selskaper basert på materiell, ikke-offentlig informasjon. Dette betyr ikke at det er ulovlig for dem å gjøre any handler i deres egne selskaper. Imidlertid må de rapportere alle handler til SEC via en Form 4.

Insiderliste og lønnsomhetsmålinger

Denne tabellen viser listen over kjente insidere, og er automatisk generert fra arkiveringer offentliggjort av SEC. I tillegg til navn, siste tittel og direktør-, offiser- eller 10 % eier-betegnelse, gir vi de nyeste offentliggjorte beholdningene. I tillegg gir vi, når det er mulig, den historiske handelsytelsen for insidere. Den historiske handelsytelsen er et vektet gjennomsnitt av ytelsen til faktiske kjøpstransaksjoner som er gjort av insidere på det åpne markedet. For mer informasjon om hvordan dette blir beregnet, kan du se dette YouTube-webinaret.

See our leaderboard of most profitable insider traders.

Innsider	Gjennomsnittlig fortjeneste (%)	Aksjer eid	Splitt justert

Report errors via our new Insider Auditing Tool

Analyse av sporrekord for insiderkjøp - Kortsiktig lønnsomhetsanalyse

I denne seksjonen analyserer vi lønnsomheten til hver ikke-planlagte, åpne markeds innsidekjøp gjort i RUBY / Rubius Therapeutics, Inc.. Denne analysen hjelper til med å forstå om insidere konsekvent genererer unormale avkastninger og er verdt å følge. Denne analysen gjelder for ett år etter hver handel, og resultatene er teoretiske .

Følgende tabell viser de mest nylige åpne markedskjøpene som ikke var en del av en automatisk handelsplan.

Handelsdato	Innsider	Rapporterte aksjer	Rapportert pris	Justert aksjer	Justert pris	Kostnadsgrunnlag	Dager til maks	Pris ved maks	Maks fortjeneste	Maks avkastning (%)
2022-04-21	Epstein David R	30 000	1,4443	30 000	1,4443	43 329	4	1.8700	12 771	29,47
2021-03-19	Flagship Ventures Fund IV General Partner LLC	70 000	29,0000	70 000	29,0000	2 030 000
2021-03-19	Flagship Ventures Fund IV General Partner LLC	70 000	29,0000	70 000	29,0000	2 030 000
2021-03-19	Flagship Ventures Fund IV General Partner LLC	70 000	29,0000	70 000	29,0000	2 030 000
2020-04-22	Coughlin Christina M.	19 000	5,5165	19 000	5,5165	104 814
2020-04-14	CAGNONI PABLO J	21 000	4,6997	21 000	4,6997	98 694
2020-03-17	Epstein David R	5 000	3,7600	5 000	3,7600	18 800
2020-03-13	Epstein David R	5 000	4,0000	5 000	4,0000	20 000
2020-03-13	Epstein David R	5 000	3,8200	5 000	3,8200	19 100

Justert pris er prisen justert for splitt. Justerte aksjer er aksjer justert for splitt.

RUBY / Rubius Therapeutics, Inc. Insider Trades

Analyse av sporrekord for insidesalg - Kortsiktig tapanalyse

I denne seksjonen analyserer vi kortsiktig tap til hver ikke-planlagte, åpne markeds innsidekjøp gjort i RUBY / Rubius Therapeutics, Inc.. Et konsekvent mønster av tap unngåelse kan antyde at fremtidige salgstransaksjoner kan forutsi nedgang i pris. Denne analysen gjelder for ett år etter hver handel, og resultatene er teoretiske .

Følgende tabell viser de mest nylige åpne markedssalgene som ikke var en del av en automatisk trading plan.

Handelsdato	Innsider	Rapporterte aksjer	Rapportert pris	Justert aksjer	Justert pris	Kostnadsgrunnlag	Dager til min	Pris ved min	Maks tap ungått ($)	Maks tap ungått (%)
2023-02-24	Appelhans Dannielle	10 385	0,1274	10 385	0,1274	1 323	28	0.0153	−1 164	−87,99
2023-02-01	Appelhans Dannielle	3 878	0,2500	3 878	0,2500	970
2023-02-01	CAGNONI PABLO J	8 448	0,2500	8 448	0,2500	2 112
2023-01-31	Turka Laurence A.	2 593	0,2400	2 593	0,2400	622
2023-01-31	CAGNONI PABLO J	7 240	0,2410	7 240	0,2410	1 745
2022-08-10	Appelhans Dannielle	5 737	0,8000	5 737	0,8000	4 590
2022-02-01	Keson-Brookes Maiken	2 732	6,5730	2 732	6,5730	17 957
2022-02-01	CAGNONI PABLO J	6 730	6,5730	6 730	6,5730	44 236
2022-02-01	Turka Laurence A.	2 517	6,5730	2 517	6,5730	16 544

Justert pris er prisen justert for splitt. Justerte aksjer er aksjer justert for splitt.

Transaksjonshistorikk

Klikk på lenkeikonet for å se hele transaksjonshistorikken. Transaksjoner rapportert som en del av en automatisk handelsplan 10b5-1 vil ha en X i kolonnen merket 10b-5.

Fil dato	Handels dato	Skjema	Innsider	Ticker	Verdipapirnavn	Kode	Direkte	Utøvelses pris	Enhets pris	Enheter endret	Verdi endret (1K)	Gjenværende Opsjoner	Gjenværende Aksjer
2023-02-27	2023-02-24	4	Appelhans Dannielle	RUBY	Common Stock	S - Sale	D		0,1274	−10 385	−1		0
2023-02-01	2023-02-01	4	CAGNONI PABLO J	RUBY	Common Stock	S - Sale	D		0,2500	−8 448	−2		66 082
2023-02-01	2023-02-01	4	Appelhans Dannielle	RUBY	Common Stock	S - Sale	D		0,2500	−3 878	−1		10 385
2023-02-01	2023-01-31	4	Appelhans Dannielle	RUBY	Common Stock	M - Exercise	D			7 500			14 263
2023-01-31	2023-01-31	4	CAGNONI PABLO J	RUBY	Common Stock	S - Sale	D		0,2410	−7 240	−2		74 530
2023-01-31	2023-01-31	4	CAGNONI PABLO J	RUBY	Common Stock	M - Exercise	D			25 000			81 770
2023-01-31	2023-01-29	4	CAGNONI PABLO J	RUBY	Common Stock	M - Exercise	D			21 250			56 770
2023-01-31	2023-01-31	4	Turka Laurence A.	RUBY	Common Stock	S - Sale	D		0,2400	−2 593	−1		18 391
2023-01-31	2023-01-31	4	Turka Laurence A.	RUBY	Common Stock	M - Exercise	D			8 625			20 984
2023-01-31	2023-01-29	4	Turka Laurence A.	RUBY	Common Stock	M - Exercise	D			7 438			12 359
2022-08-12	2022-08-10	4	Appelhans Dannielle	RUBY	Common Stock	S - Sale	D		0,8000	−5 737	−5		6 763
2022-08-12	2022-08-09	4	Appelhans Dannielle	RUBY	Common Stock	M - Exercise	D			12 500			12 500
2022-05-13	2022-05-12	4	Holles Natalie C.	RUBY	Stock Option (Right to Buy)	A - Award	D	1,24		25 000		25 000
2022-05-13	2022-05-12	4	Prener Anne	RUBY	Stock Option (Right to Buy)	A - Award	D	1,24		25 000		25 000
2022-05-13	2022-05-12	4	Symonds Jonathan	RUBY	Stock Option (Right to Buy)	A - Award	D	1,24		25 000		25 000
2022-05-13	2022-05-12	4	AFEYAN NOUBAR	RUBY	Stock Option (Right to Buy)	A - Award	D	1,24		25 000		25 000
2022-05-13	2022-05-12	4	Cuss Francis M	RUBY	Stock Option (Right to Buy)	A - Award	D	1,24		25 000		25 000
2022-05-13	2022-05-12	4	Rosenblatt Michael	RUBY	Stock Option (Right to Buy)	A - Award	D	1,24		25 000		25 000
2022-05-13	2022-05-12	4	Sohn Catherine A.	RUBY	Stock Option (Right to Buy)	A - Award	D	1,24		25 000		25 000
2022-05-13	2022-05-12	4	Epstein David R	RUBY	Stock Option (Right to Buy)	A - Award	D	1,24		499 762		499 762
2022-04-22	2022-04-21	4	Epstein David R	RUBY	Common Stock	P - Purchase	D		1,4443	30 000	43		4 720 012
2022-02-14	2021-06-16	5	CAGNONI PABLO J	RUBY	Common Stock	G - Gift	D			−2 200			29 320
2022-02-14	2021-04-26	5	CAGNONI PABLO J	RUBY	Common Stock	G - Gift	D			−4 000			31 520
2022-02-01	2022-01-31	4	Carmona Jose	RUBY	Restricted Stock Units	A - Award	D			34 500		34 500
2022-02-01	2022-01-31	4	Carmona Jose	RUBY	Stock Option (Right to Buy)	A - Award	D	6,75		143 750		143 750
2022-02-01	2022-02-01	4	CAGNONI PABLO J	RUBY	Common Stock	S - Sale	D		6,5730	−6 730	−44		35 520
2022-02-01	2022-01-31	4	CAGNONI PABLO J	RUBY	Restricted Stock Units	A - Award	D			100 000		100 000
2022-02-01	2022-01-31	4	CAGNONI PABLO J	RUBY	Stock Option (Right to Buy)	A - Award	D	6,75		365 000		365 000
2022-02-01	2022-01-29	4	CAGNONI PABLO J	RUBY	Restricted Stock Units	M - Exercise	D			−21 250		63 750
2022-02-01	2022-01-29	4	CAGNONI PABLO J	RUBY	Common Stock	M - Exercise	D			21 250			42 250
2022-02-01	2022-02-01	4	Keson-Brookes Maiken	RUBY	Common Stock	S - Sale	D		6,5730	−2 732	−18		5 343
2022-02-01	2022-01-31	4	Keson-Brookes Maiken	RUBY	Restricted Stock Units	A - Award	D			34 500		34 500
2022-02-01	2022-01-31	4	Keson-Brookes Maiken	RUBY	Stock Option (Right to Buy)	A - Award	D	6,75		143 750		143 750
2022-02-01	2022-01-29	4	Keson-Brookes Maiken	RUBY	Restricted Stock Units	M - Exercise	D			−8 075		24 225
2022-02-01	2022-01-29	4	Keson-Brookes Maiken	RUBY	Common Stock	M - Exercise	D			8 075			8 075
2022-02-01	2022-01-31	4	Appelhans Dannielle	RUBY	Restricted Stock Units	A - Award	D			30 000		30 000
2022-02-01	2022-01-31	4	Appelhans Dannielle	RUBY	Stock Option (Right to Buy)	A - Award	D	6,75		125 000		125 000
2022-02-01	2022-02-01	4	Turka Laurence A.	RUBY	Common Stock	S - Sale	D		6,5730	−2 517	−17		4 921
2022-02-01	2022-01-31	4	Turka Laurence A.	RUBY	Restricted Stock Units	A - Award	D			34 500		34 500
2022-02-01	2022-01-31	4	Turka Laurence A.	RUBY	Stock Option (Right to Buy)	A - Award	D	6,75		143 750		143 750
2022-02-01	2022-01-29	4	Turka Laurence A.	RUBY	Restricted Stock Units	M - Exercise	D			−7 438		22 312
2022-02-01	2022-01-29	4	Turka Laurence A.	RUBY	Common Stock	M - Exercise	D			7 438			7 438
2021-09-01	2021-08-31	4	Appelhans Dannielle	RUBY	Restricted Stock Units	A - Award	D			50 000		50 000
2021-09-01	2021-08-31	4	Appelhans Dannielle	RUBY	Stock Option (Right to Buy)	A - Award	D	21,72		150 000		150 000
2021-05-13	2021-05-12	4	Prener Anne	RUBY	Stock Option (Right to Buy)	A - Award	D	23,25		25 000		25 000
2021-05-13	2021-05-12	4	Cuss Francis M	RUBY	Stock Option (Right to Buy)	A - Award	D	23,25		25 000		25 000
2021-05-13	2021-05-12	4	AFEYAN NOUBAR	RUBY	Stock Option (Right to Buy)	A - Award	D	23,25		25 000		25 000
2021-05-13	2021-05-12	4	Sohn Catherine A.	RUBY	Stock Option (Right to Buy)	A - Award	D	23,25		25 000		25 000
2021-05-13	2021-05-12	4	Rosenblatt Michael	RUBY	Stock Option (Right to Buy)	A - Award	D	23,25		25 000		25 000
2021-05-13	2021-05-12	4	Epstein David R	RUBY	Stock Option (Right to Buy)	A - Award	D	23,25		27 919		27 919
2021-05-13	2021-05-12	4	Holles Natalie C.	RUBY	Stock Option (Right to Buy)	A - Award	D	23,25		25 000		25 000
2021-05-13	2021-05-12	4	Symonds Jonathan	RUBY	Stock Option (Right to Buy)	A - Award	D	23,25		25 000		25 000
2021-03-23	2021-03-19	4	Flagship Ventures Fund IV General Partner LLC	RUBY	Common Stock	P - Purchase	I		29,0000	70 000	2 030		2 633 703
2021-03-23	2021-03-19	4	Flagship Ventures Fund IV General Partner LLC	RUBY	Common Stock	P - Purchase	I		29,0000	70 000	2 030		2 633 703
2021-03-23	2021-03-19	4	Flagship Ventures Fund IV General Partner LLC	RUBY	Common Stock	P - Purchase	I		29,0000	70 000	2 030		15 393 593
2021-03-15	2021-03-15	4	Keson-Brookes Maiken	RUBY	Stock Option (Right to Buy)	M - Exercise	D	7,70		−25 000		225 000
2021-03-15	2021-03-15	4	Keson-Brookes Maiken	RUBY	Common Stock	S - Sale	D		20,2386	−25 000	−506		0
2021-03-15	2021-03-15	4	Keson-Brookes Maiken	RUBY	Common Stock	M - Exercise	D		7,7000	25 000	192		25 000
2021-02-16	2021-02-11	4	Epstein David R	RUBY	Common Stock	S - Sale	D		14,9251	−26 704	−399		4 690 012
2021-02-10	2021-02-10	4	Epstein David R	RUBY	Common Stock	S - Sale	D		14,7927	−7 404	−110		4 716 716
2021-02-10	2021-02-09	4	Epstein David R	RUBY	Common Stock	S - Sale	D		14,8314	−2 100	−31		4 724 120
2021-02-10	2021-02-08	4	Epstein David R	RUBY	Common Stock	S - Sale	D		14,8837	−89 233	−1 328		4 726 220
2021-02-02	2021-01-29	4	CAGNONI PABLO J	RUBY	Restricted Stock Units	A - Award	D			85 000		85 000
2021-02-02	2021-01-29	4	CAGNONI PABLO J	RUBY	Stock Option (Right to Buy)	A - Award	D	11,97		375 000		375 000
2021-02-02	2021-01-29	4	Keson-Brookes Maiken	RUBY	Restricted Stock Units	A - Award	D			32 300		32 300
2021-02-02	2021-01-29	4	Keson-Brookes Maiken	RUBY	Stock Option (Right to Buy)	A - Award	D	11,97		142 500		142 500
2021-02-02	2021-01-29	4	Turka Laurence A.	RUBY	Restricted Stock Units	A - Award	D			29 750		29 750
2021-02-02	2021-01-29	4	Turka Laurence A.	RUBY	Stock Option (Right to Buy)	A - Award	D	11,97		131 250		131 250
2021-02-02	2021-01-29	4	Coughlin Christina M.	RUBY	Restricted Stock Units	A - Award	D			32 300		32 300
2021-02-02	2021-01-29	4	Coughlin Christina M.	RUBY	Stock Option (Right to Buy)	A - Award	D	11,97		142 500		142 500
2020-12-02	2020-11-30	4	Carmona Jose	RUBY	Stock Option (Right to Buy)	A - Award	D	6,27		400 000		400 000
2020-05-26	2020-05-21	4	Holles Natalie C.	RUBY	Stock Option (Right to Buy)	A - Award	D	6,22		25 000		25 000
2020-05-26	2020-05-21	4	Epstein David R	RUBY	Stock Option (Right to Buy)	A - Award	D	6,22		115 771		115 771
2020-05-26	2020-05-21	4	Symonds Jonathan	RUBY	Stock Option (Right to Buy)	A - Award	D	6,22		25 000		25 000
2020-05-26	2020-05-21	4	AFEYAN NOUBAR	RUBY	Stock Option (Right to Buy)	A - Award	D	6,22		25 000		25 000
2020-05-26	2020-05-21	4	Sohn Catherine A.	RUBY	Stock Option (Right to Buy)	A - Award	D	6,22		25 000		25 000
2020-05-26	2020-05-21	4	Rosenblatt Michael	RUBY	Stock Option (Right to Buy)	A - Award	D	6,22		25 000		25 000
2020-05-26	2020-05-21	4	Cuss Francis M	RUBY	Stock Option (Right to Buy)	A - Award	D	6,22		25 000		25 000
2020-05-19	2020-05-15	4	OH ANDREW M.	RUBY	Stock Option (Right to Buy)	M - Exercise	D	4,74		−5 000		755 500
2020-05-19	2020-05-15	4	OH ANDREW M.	RUBY	Common Stock	M - Exercise	D		4,7400	5 000	24		5 000
2020-04-24	2020-04-22	4	Coughlin Christina M.	RUBY	Common Stock	P - Purchase	D		5,5165	19 000	105		19 000
2020-04-15	2020-04-14	4	CAGNONI PABLO J	RUBY	Common Stock	P - Purchase	D		4,6997	21 000	99		21 000
2020-03-19	2020-03-17	4	Epstein David R	RUBY	Common Stock	P - Purchase	D		3,7600	5 000	19		4 815 453
2020-03-17	2020-03-13	4	Epstein David R	RUBY	Common Stock	P - Purchase	D		4,0000	5 000	20		4 810 453
2020-03-17	2020-03-13	4	Epstein David R	RUBY	Common Stock	P - Purchase	D		3,8200	5 000	19		4 805 453
2020-02-03	2020-01-31	4	OH ANDREW M.	RUBY	Stock Option (Right to Buy)	A - Award	D	7,80		165 000		165 000
2020-02-03	2020-01-31	4	Turka Laurence A.	RUBY	Stock Option (Right to Buy)	A - Award	D	7,80		350 000		350 000
2020-02-03	2020-01-31	4	CAGNONI PABLO J	RUBY	Stock Option (Right to Buy)	A - Award	D	7,80		500 000		500 000
2020-02-03	2020-01-31	4	Coughlin Christina M.	RUBY	Stock Option (Right to Buy)	A - Award	D	7,80		375 000		375 000
2020-01-03	2019-12-31	4	Prener Anne	RUBY	Stock Option (Right to Buy)	A - Award	D	9,50		50 000		50 000
2019-12-18	2019-12-16	4	CARPENTER CHRISTOPHER L.	RUBY	Stock Option (Right to Buy)	M - Exercise	D	2,87		−48 000		523 157
2019-12-18	2019-12-16	4	CARPENTER CHRISTOPHER L.	RUBY	Common Stock	S - Sale	D		13,4771	−48 000	−647		34 843
2019-12-18	2019-12-16	4	CARPENTER CHRISTOPHER L.	RUBY	Common Stock	M - Exercise	D		2,8700	48 000	138		82 843
2019-12-03	2019-11-29	4	Keson-Brookes Maiken	RUBY	Stock Option (Right to Buy)	A - Award	D	7,70		250 000		250 000
2019-10-17	2019-10-14	4	LANGER ROBERT	RUBY	Stock Option (Right to Buy)	M - Exercise	D	0,15		−7 500		120 000
2019-10-17	2019-10-14	4	LANGER ROBERT	RUBY	Common Stock	S - Sale	D		8,5166	−7 500	−64		0
2019-10-17	2019-10-14	4	LANGER ROBERT	RUBY	Common Stock	M - Exercise	D		0,1500	7 500	1		7 500
2019-09-18	2019-09-17	4	CARPENTER CHRISTOPHER L.	RUBY	Stock Option (Right to Buy)	M - Exercise	D	2,87		−11 877		571 157
2019-09-18	2019-09-17	4	CARPENTER CHRISTOPHER L.	RUBY	Common Stock	S - Sale	D		10,0454	−11 877	−119		34 843
2019-09-18	2019-09-17	4	CARPENTER CHRISTOPHER L.	RUBY	Common Stock	M - Exercise	D		2,8700	11 877	34		46 720
2019-09-18	2019-09-16	4	CARPENTER CHRISTOPHER L.	RUBY	Stock Option (Right to Buy)	M - Exercise	D	2,87		−36 123		583 034
2019-09-18	2019-09-16	4	CARPENTER CHRISTOPHER L.	RUBY	Common Stock	S - Sale	D		10,1292	−36 123	−366		34 843
2019-09-18	2019-09-16	4	CARPENTER CHRISTOPHER L.	RUBY	Common Stock	M - Exercise	D		2,8700	36 123	104		70 966
2019-07-26	2019-07-24	4	NISSEN TORBEN STRAIGHT	RUBY	Stock Option (Right to Buy)	M - Exercise	D	0,19		−32 146		82 854
2019-07-26	2019-07-24	4	NISSEN TORBEN STRAIGHT	RUBY	Stock Option (Right to Buy)	M - Exercise	D	0,18		−175 000		175 000
2019-07-26	2019-07-24	4	NISSEN TORBEN STRAIGHT	RUBY	Common Stock	M - Exercise	D		0,1900	32 146	6		2 052 450
2019-07-26	2019-07-24	4	NISSEN TORBEN STRAIGHT	RUBY	Common Stock	M - Exercise	D		0,1800	175 000	32		2 020 304
2019-07-17	2019-07-15	4	LANGER ROBERT	RUBY	Stock Option (Right to Buy)	M - Exercise	D	0,15		−7 500		127 500
2019-07-17	2019-07-15	4	LANGER ROBERT	RUBY	Common Stock	S - Sale	D		14,9398	−7 500	−112		0
2019-07-17	2019-07-15	4	LANGER ROBERT	RUBY	Common Stock	M - Exercise	D		0,1500	7 500	1		7 500
2019-06-24	2019-06-20	4	CARPENTER CHRISTOPHER L.	RUBY	Stock Option (Right to Buy)	M - Exercise	D	2,87		−243		619 157
2019-06-24	2019-06-20	4	CARPENTER CHRISTOPHER L.	RUBY	Common Stock	S - Sale	D		13,9340	−243	−3		34 843
2019-06-24	2019-06-20	4	CARPENTER CHRISTOPHER L.	RUBY	Common Stock	M - Exercise	D		2,8700	243	1		35 086
2019-06-19	2019-06-19	4	CARPENTER CHRISTOPHER L.	RUBY	Stock Option (Right to Buy)	M - Exercise	D	2,87		−18 399		619 400
2019-06-19	2019-06-19	4	CARPENTER CHRISTOPHER L.	RUBY	Common Stock	S - Sale	D		13,7979	−18 399	−254		34 843
2019-06-19	2019-06-19	4	CARPENTER CHRISTOPHER L.	RUBY	Common Stock	M - Exercise	D		2,8700	18 399	53		53 242
2019-06-19	2019-06-18	4	CARPENTER CHRISTOPHER L.	RUBY	Stock Option (Right to Buy)	M - Exercise	D	2,87		−10 858		637 799
2019-06-19	2019-06-18	4	CARPENTER CHRISTOPHER L.	RUBY	Common Stock	S - Sale	D		14,2713	−10 858	−155		34 843
2019-06-19	2019-06-18	4	CARPENTER CHRISTOPHER L.	RUBY	Common Stock	M - Exercise	D		2,8700	10 858	31		45 701
2019-06-19	2019-06-17	4	CARPENTER CHRISTOPHER L.	RUBY	Stock Option (Right to Buy)	M - Exercise	D	2,87		−18 500		648 657
2019-06-19	2019-06-17	4	CARPENTER CHRISTOPHER L.	RUBY	Common Stock	S - Sale	D		14,1010	−18 500	−261		34 843
2019-06-19	2019-06-17	4	CARPENTER CHRISTOPHER L.	RUBY	Common Stock	M - Exercise	D		2,8700	18 500	53		53 343
2019-05-28	2019-05-23	4	Cuss Francis M	RUBY	Stock Option (Right to Buy)	A - Award	D	16,27		25 000		25 000
2019-05-28	2019-05-23	4	Epstein David R	RUBY	Stock Option (Right to Buy)	A - Award	D	16,27		39 094		39 094
2019-05-28	2019-05-23	4	LANGER ROBERT	RUBY	Stock Option (Right to Buy)	A - Award	D	16,27		25 000		25 000
2019-05-28	2019-05-23	4	Rosenblatt Michael	RUBY	Stock Option (Right to Buy)	A - Award	D	16,27		25 000		25 000
2019-05-28	2019-05-23	4	Sohn Catherine A.	RUBY	Stock Option (Right to Buy)	A - Award	D	16,27		25 000		25 000
2019-05-28	2019-05-23	4	Symonds Jonathan	RUBY	Stock Option (Right to Buy)	A - Award	D	16,27		25 000		25 000
2019-05-28	2019-05-23	4	AFEYAN NOUBAR	RUBY	Stock Option (Right to Buy)	A - Award	D	16,27		25 000		25 000
2019-04-17	2019-04-15	4	LANGER ROBERT	RUBY	Stock Option (Right to Buy)	M - Exercise	D	0,15		−7 500		135 000
2019-04-17	2019-04-15	4	LANGER ROBERT	RUBY	Common Stock	S - Sale	D		17,5732	−7 500	−132		0
2019-04-17	2019-04-15	4	LANGER ROBERT	RUBY	Common Stock	M - Exercise	D		0,1500	7 500	1		7 500
2019-04-10	2019-04-08	4	NISSEN TORBEN STRAIGHT	RUBY	Common Stock	S - Sale	D		20,0000	−2 100	−42		1 845 304
2019-04-05	2019-04-05	4	NISSEN TORBEN STRAIGHT	RUBY	Common Stock	S - Sale	D		20,0000	−12 096	−242		1 847 404
2019-04-05	2019-04-03	4	NISSEN TORBEN STRAIGHT	RUBY	Common Stock	S - Sale	D		20,0000	−500	−10		1 859 500
2019-04-01	2019-03-29	4	Holles Natalie C.	RUBY	Stock Option (Right to Buy)	A - Award	D	18,10		50 000		50 000
2019-03-19	2019-03-15	4	CARPENTER CHRISTOPHER L.	RUBY	Stock Option (Right to Buy)	M - Exercise	D	2,87		−48 000		667 157
2019-03-19	2019-03-15	4	CARPENTER CHRISTOPHER L.	RUBY	Common Stock	S - Sale	D		15,8357	−48 000	−760		34 843
2019-03-19	2019-03-15	4	CARPENTER CHRISTOPHER L.	RUBY	Common Stock	M - Exercise	D		2,8700	48 000	138		82 843
2019-02-14	2018-11-28	5	Epstein David R By Three Opinions Foundation Inc.	RUBY	Common Stock	G - Gift	I			180 000			180 000
2019-02-14	2018-11-28	5	Epstein David R	RUBY	Common Stock	G - Gift	D			−180 000			4 800 453
2019-02-04	2019-01-31	4	CAGNONI PABLO J	RUBY	Stock Option (Right to Buy)	A - Award	D	13,69		100 000		100 000
2019-02-04	2019-01-31	4	NISSEN TORBEN STRAIGHT	RUBY	Stock Option (Right to Buy)	A - Award	D	13,69		175 000		175 000
2019-02-04	2019-01-31	4	CARPENTER CHRISTOPHER L.	RUBY	Stock Option (Right to Buy)	A - Award	D	13,69		100 000		100 000
2019-02-04	2019-01-31	4	OH ANDREW M.	RUBY	Stock Option (Right to Buy)	A - Award	D	13,69		115 000		115 000
2019-01-24	2019-01-22	4	CARPENTER CHRISTOPHER L.	RUBY	Stock Option (Right to Buy)	M - Exercise	D	2,87		−34 843		715 157
2019-01-24	2019-01-22	4	CARPENTER CHRISTOPHER L.	RUBY	Common Stock	M - Exercise	D		2,8700	34 843	100		34 843
2019-01-18	2019-01-14	4	LANGER ROBERT	RUBY	Stock Option (Right to Buy)	M - Exercise	D	0,15		−7 500		142 500
2019-01-18	2019-01-14	4	LANGER ROBERT	RUBY	Common Stock	S - Sale	D		14,5925	−7 500	−109		0
2019-01-18	2019-01-14	4	LANGER ROBERT	RUBY	Common Stock	M - Exercise	D		0,1500	7 500	1		7 500
2018-11-01	2018-10-31	4	CAGNONI PABLO J	RUBY	Stock Option (Right to Buy)	A - Award	D	16,43		193 400		193 400
2018-11-01	2018-10-31	4	CAGNONI PABLO J	RUBY	Stock Option (Right to Buy)	A - Award	D	16,43		164 400		164 400
2018-07-23	2018-07-20	4	Symonds Jonathan	RUBY	Common Stock	P - Purchase	D		23,0000	25 000	575		25 000
2018-07-23	2018-07-20	4	Cuss Francis M	RUBY	Common Stock	P - Purchase	D		23,0000	10 000	230		10 000
2018-07-23	2018-07-20	4	Pomerantz Roger	RUBY	Common Stock	P - Purchase	D		23,0000	100	2		100
2018-07-23	2018-07-20	4	Sohn Catherine A.	RUBY	Common Stock	P - Purchase	D		23,0000	2 500	58		2 500
2018-07-23	2018-07-20	4	Flagship Ventures Fund IV General Partner LLC	RUBY	Series C Preferred Stock	C - Conversion	I			−781 860		0
2018-07-23	2018-07-20	4	Flagship Ventures Fund IV General Partner LLC	RUBY	Series C Preferred Stock	C - Conversion	I			−195 466		0
2018-07-23	2018-07-20	4	Flagship Ventures Fund IV General Partner LLC	RUBY	Series C Preferred Stock	C - Conversion	I			−195 466		0
2018-07-23	2018-07-20	4	Flagship Ventures Fund IV General Partner LLC	RUBY	Series B Preferred Stock	C - Conversion	I			−1 781 843		0
2018-07-23	2018-07-20	4	Flagship Ventures Fund IV General Partner LLC	RUBY	Series B Preferred Stock	C - Conversion	I			−593 948		0
2018-07-23	2018-07-20	4	Flagship Ventures Fund IV General Partner LLC	RUBY	Series B Preferred Stock	C - Conversion	I			−593 948		0
2018-07-23	2018-07-20	4	Flagship Ventures Fund IV General Partner LLC	RUBY	Series A Preferred Stock	C - Conversion	I			−5 000 000		0
2018-07-23	2018-07-20	4	Flagship Ventures Fund IV General Partner LLC	RUBY	Series A Preferred Stock	C - Conversion	I			−5 000 000		0
2018-07-23	2018-07-20	4	Flagship Ventures Fund IV General Partner LLC	RUBY	Series A Preferred Stock	C - Conversion	I			−3 830 402		0
2018-07-23	2018-07-20	4	Flagship Ventures Fund IV General Partner LLC	RUBY	Series A Preferred Stock	C - Conversion	I			−15 323 593		0
2018-07-23	2018-07-20	4	Flagship Ventures Fund IV General Partner LLC	RUBY	Common Stock	C - Conversion	I			781 860			2 563 703
2018-07-23	2018-07-20	4	Flagship Ventures Fund IV General Partner LLC	RUBY	Common Stock	C - Conversion	I			195 466			5 789 414
2018-07-23	2018-07-20	4	Flagship Ventures Fund IV General Partner LLC	RUBY	Common Stock	C - Conversion	I			195 466			5 789 414
2018-07-23	2018-07-20	4	Flagship Ventures Fund IV General Partner LLC	RUBY	Common Stock	C - Conversion	I			1 781 843			1 781 843
2018-07-23	2018-07-20	4	Flagship Ventures Fund IV General Partner LLC	RUBY	Common Stock	C - Conversion	I			593 948			5 593 948
2018-07-23	2018-07-20	4	Flagship Ventures Fund IV General Partner LLC	RUBY	Common Stock	C - Conversion	I			593 948			5 593 948
2018-07-23	2018-07-20	4	Flagship Ventures Fund IV General Partner LLC	RUBY	Common Stock	C - Conversion	I			5 000 000			5 000 000
2018-07-23	2018-07-20	4	Flagship Ventures Fund IV General Partner LLC	RUBY	Common Stock	C - Conversion	I			5 000 000			5 000 000
2018-07-23	2018-07-20	4	Flagship Ventures Fund IV General Partner LLC	RUBY	Common Stock	C - Conversion	I			3 830 402			3 830 402
2018-07-23	2018-07-20	4	Flagship Ventures Fund IV General Partner LLC	RUBY	Common Stock	C - Conversion	I			15 323 593			15 323 593
2018-07-18	2018-07-17	4	Symonds Jonathan	RUBY	Stock Option (Right to Buy)	A - Award	D	23,00		25 000		25 000
2018-07-18	2018-07-17	4	Cuss Francis M	RUBY	Stock Option (Right to Buy)	A - Award	D	23,00		25 000		25 000
2018-07-18	2018-07-17	4	Epstein David R	RUBY	Stock Option (Right to Buy)	A - Award	D	23,00		1 902 977		1 902 977
2018-07-18	2018-07-17	4	Sohn Catherine A.	RUBY	Stock Option (Right to Buy)	A - Award	D	23,00		25 000		25 000
2018-07-18	2018-07-17	4	Rosenblatt Michael	RUBY	Stock Option (Right to Buy)	A - Award	D	23,00		25 000		25 000
2018-07-18	2018-07-17	4	LANGER ROBERT	RUBY	Stock Option (Right to Buy)	A - Award	D	23,00		25 000		25 000
2018-07-18	2018-07-17	4	Pomerantz Roger	RUBY	Stock Option (Right to Buy)	A - Award	D	23,00		25 000		25 000
2018-07-18	2018-07-17	4	AFEYAN NOUBAR	RUBY	Stock Option (Right to Buy)	A - Award	D	23,00		25 000		25 000
2018-07-17		3	Epstein David R	RUBY	Common Stock		D						9 960 906
2018-07-17		3	Epstein David R	RUBY	Common Stock		D						9 960 906
2018-07-17		3	Epstein David R	RUBY	Common Stock		D						9 960 906
2018-07-17		3	NISSEN TORBEN STRAIGHT	RUBY	Common Stock		D						3 720 000
2018-07-17		3	NISSEN TORBEN STRAIGHT	RUBY	Common Stock		D						3 720 000
2018-07-17		3	NISSEN TORBEN STRAIGHT	RUBY	Common Stock		D						3 720 000
2018-07-17		3	KANIA EDWIN M JR	RUBY	Common Stock		I						10 000 000
2018-07-17		3	KANIA EDWIN M JR	RUBY	Common Stock		I						10 000 000
2018-07-17		3	KANIA EDWIN M JR	RUBY	Common Stock		I						10 000 000
2018-07-17		3	KANIA EDWIN M JR	RUBY	Common Stock		I						10 000 000
2018-07-17		3	KANIA EDWIN M JR	RUBY	Common Stock		I						10 000 000
2018-07-17		3	KANIA EDWIN M JR	RUBY	Common Stock		I						10 000 000
2018-07-17		3	KANIA EDWIN M JR	RUBY	Common Stock		I						10 000 000
2018-07-17		3	KANIA EDWIN M JR	RUBY	Common Stock		I						10 000 000
2018-07-17		3	KANIA EDWIN M JR	RUBY	Common Stock		I						10 000 000
2018-07-17		3	KANIA EDWIN M JR	RUBY	Common Stock		I						10 000 000
2018-07-17		3	KANIA EDWIN M JR	RUBY	Common Stock		I						10 000 000

Åpent marked eller private kjøp av ikke-derivat eller derivat sikkerhet.

Bevilgning, tildeling eller andre oppkjøp av verdipapirer fra selskapet (slik som en opsjon)

Konvertering av derivat

Salg eller overføring av verdipapirer tilbake til selskapet

Betaling av utøvelseskurs eller skatteplikt ved å bruke deler av verdipapirer mottat fra selskapet

Gave av verdipapirer fra eller til insidere

Aksjebytting og lignende sikringsavtaler

Øvelse eller konvertering av derivatverdipapir mottatt fra selskapet (for eksempel en opsjon)

En transaksjon frivilig rapportert på Skjema 4

Annet (med en fotnote som beskriver transaksjonen)

RUBY / Rubius Therapeutics, Inc. - Insider Trading and Ownership Report - SEC Form 3, 4, 5